Milestone Scientific Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2024 Annual Meeting of Stockholders held on December 18, 2025. Milestone Scientific Inc. (MLSS), incorporated in Delaware, is listed on the NYSE American. The filing details the outcomes of three proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
Stockholders approved the following matters at the Annual Meeting:
- Director Elections: Six incumbent directors were elected. The average vote "For" was 92.84%, with an average "Withheld" rate of 7.16%.
- Authorized Share Increase: Stockholders approved an amendment to the Restated Certificate of Incorporation to increase authorized common stock from 100,000,000 to 125,000,000 shares. This proposal received 96.18% of votes cast "For".
- Auditor Ratification: The appointment of CBIZ CPA P.C. as independent auditors for the fiscal year ending December 31, 2025, was ratified with 98.87% of votes cast "For".
Voting Participation: Of 78,628,913 shares outstanding, 48,381,413 shares (61.53%) were voted at the meeting.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of voting results.
Investor Verification Checklist
- Verify the impact of the increased authorized share count (125,000,000 shares) on potential future dilution.
- Review the full proxy statement for details on director qualifications and the specific reasons for the 7.16% average withheld vote.
- Confirm the fiscal year-end financial results for 2025 in the upcoming 10-K filing, as this 8-K does not contain financial data.